Empagliflozin for reducing risk of kidney stones

Research shows this SLGT2 inhibitor may reduce stones in people with diabetes, though how is unclear. Kidney stones (urolithiasis) are commonly seen in primary care,...

Antioxidants and mineral supplements for slowing age-related macular degeneration

Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...

PSA successfully lobbies for pharmacist recommendations

Pharmacists have been recommended to access Medicare Benefits Schedule (MBS) items to manage medicines for patients who require complex care. The Pharmaceutical Society of Australia...

Medicines as a team sport

How pharmacists can respond to Aboriginal and Torres Strait Islander community needs in an integrated, collaborative way that uses their full set of skills....

Improved medicines use must be a target of mental health reform

Mental illness has been treated as an ‘add-on to the physical health system’, the Productivity Commission has found, with up to 1 million Australians...

Government pledges to improve medicine safety in aged care

The Federal Government has committed to improving medicine safety in aged care, as part of a $537 million response to the interim report of...